Chemomab Therapeutics Ltd. American Depositary Share (NASDAQ: CMMB) last traded at $2.16, up 4.35% on the session. The quote above updates while this page is open; the figures below are drawn from Chemomab Therapeutics Ltd. American Depositary Share’s own filings and are restated only when a new one is published.
Chemomab Therapeutics Ltd. American Depositary Share trades on NASDAQ under the ticker CMMB. Its market capitalisation is $1.24 billion.
Valuation measures for Chemomab Therapeutics Ltd. American Depositary Share, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.24B |
|---|---|
| Enterprise value | $1.24B |
| P/E ratio | 120.00 |
| Price / book | 100.76 |
| Beta | 1.70 |
Trailing-twelve-month figures tagged in Chemomab Therapeutics Ltd. American Depositary Share's XBRL filings with the SEC.
| Net income (TTM) | -$8.99M |
|---|---|
| EPS (TTM) | $0.0180 |
| Return on equity | -72.93% |
| Cash | $7.56M |
Range and volume for CMMB over the past 52 weeks.
| 52-week high | $4.12 |
|---|---|
| 52-week low | $1.35 |
| Volume | 107.0K |
| Average volume | 132.7K |
| Previous close | $2.07 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.